43
Participants
Start Date
March 31, 2006
Primary Completion Date
October 31, 2008
Study Completion Date
October 31, 2008
Infliximab Increased Frequency
Continuing the same dose of 3 mg/kg infliximab, but at every 6 weeks for 24 weeks
Infliximab Increased Dose
3 mg/kg infliximab + 1 extra vial (100 mg) infliximab every 8 weeks for 24 weeks
Infliximab Control
Continuation of infliximab 3 mg/kg every 8 weeks for 24 weeks
Collaborators (1)
Integrated Therapeutics Group
INDUSTRY
Merck Sharp & Dohme LLC
INDUSTRY